| Literature DB >> 29556002 |
Matteo Ugolini1, Jenny Gerhard1, Sanne Burkert2, Kristoffer Jarlov Jensen3,4, Philipp Georg1, Friederike Ebner5, Sarah M Volkers1, Shruthi Thada2,6, Kristina Dietert7, Laura Bauer8, Alexander Schäfer9, Elisa T Helbig1, Bastian Opitz1,10, Florian Kurth1, Saubashya Sur2, Nickel Dittrich2, Sumanlatha Gaddam6,11, Melanie L Conrad12, Christine S Benn3,13, Ulrike Blohm9, Achim D Gruber7, Andreas Hutloff8, Susanne Hartmann5, Mark V Boekschoten14, Michael Müller14,15, Gregers Jungersen4, Ralf R Schumann2, Norbert Suttorp1,10, Leif E Sander16,17.
Abstract
Live attenuated vaccines are generally highly efficacious and often superior to inactivated vaccines, yet the underlying mechanisms of this remain largely unclear. Here we identify recognition of microbial viability as a potent stimulus for follicular helper T cell (TFH cell) differentiation and vaccine responses. Antigen-presenting cells (APCs) distinguished viable bacteria from dead bacteria through Toll-like receptor 8 (TLR8)-dependent detection of bacterial RNA. In contrast to dead bacteria and other TLR ligands, live bacteria, bacterial RNA and synthetic TLR8 agonists induced a specific cytokine profile in human and porcine APCs, thereby promoting TFH cell differentiation. In domestic pigs, immunization with a live bacterial vaccine induced robust TFH cell and antibody responses, but immunization with its heat-killed counterpart did not. Finally, a hypermorphic TLR8 polymorphism was associated with protective immunity elicited by vaccination with bacillus Calmette-Guérin (BCG) in a human cohort. We have thus identified TLR8 as an important driver of TFH cell differentiation and a promising target for TFH cell-skewing vaccine adjuvants.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29556002 DOI: 10.1038/s41590-018-0068-4
Source DB: PubMed Journal: Nat Immunol ISSN: 1529-2908 Impact factor: 25.606